In 2026, payers like UnitedHealthcare and Optum are not using manual reviewers to deny your claims. They are using AI algorithms trained to spot a single missing Z-Code or a mismatched LOINC code in milliseconds. If you are fighting these algorithms with spreadsheets and phone calls, you have already lost. Dastify Solutions is the laboratory denial management service that fights AI with AI. We do not wait for the rejection letter. We use predictive risk scoring to audit your claims against millions of payer rules before they leave your LIS.
Our "Shift-Left" Prevention Strategy
Real-Time Eligibility and Auth
For high-cost tests, we automate the Prior Authorization process. We verify eligibility and benefits at the moment of accession, ensuring the patient actually has coverage for the specific panel ordered.
Tired of Fighting AI Denials With Manual Appeals?
Our Guaranteed Results For Your Laboratory Success
KPIs that reflect our commitment to your revenue success.
Surgical Appeal Strategies for Top Lab Denials
When a denial does happen, we don’t send a form letter. We sent a forensic argument. Generic appeals get generic rejections. Our lab denial resolution team breaks down rejections by code and counter-attacks using RPA-enabled appeal submission.
We combine root cause, payer language, and our technical fix into one Technical Resolution Matrix
| Metric | The Payer's Argument | Our Solution |
|---|---|---|
| CO-50: Medical Necessity | "The diagnosis does not support this panel." | We pull the ordering provider's history and prior successes to prove longitudinal complexity capture. We attach the specific LCD article proving coverage. |
| CO-97: Bundling (CCI Edits) | "This test is included in another code." | We analyze NCCI Edits to identify if a 59 or X{EPSU} modifier is genuinely warranted. If the test is distinct, we fight for separate reimbursement. |
| CO-16: Info Missing | "Claim lacks information." | Usually a missing date of collection or referring to NPI. Our bots scrape the LIS to fill the gap and resubmit in 24 hours. |
Silent Denials & Pending Claim Liquidation (2026 Payer Edits)
In 2026, payers are increasingly using Internal Processing Edits that are not formal denials. No CARC code is issued, but the claim sits in “Pending” status indefinitely. This is the hidden “silent denial” that starves your cash flow.
We call this the “Black Hole” of pending claims.
We target this Black Hole using a dedicated Pending Claim Liquidation process. Our RPA bots continuously monitor payer portals for stalled claims and force a payer adjudication within 72 hours of submission. By driving a decision (pay or deny), we convert silent inventory into actionable revenue recovery and follow‑up.
Forensic Appeal Workflows for Hard Denials
We use Robotic Process Automation (RPA) to submit these appeals directly into payer portals. This bypasses the mailroom and puts your appeal in front of a reviewer days faster than manual submission.
The specific patient notes proving the test was vital for treatment.
We attach the exact Local Coverage Determination article that mandates coverage.
For genetic tests, we include clinical studies supporting the test's validity to counter "experimental" claims.
Claims Sitting in 'Pending' Status for Weeks With No Explanation?
2026 Regulatory Compliance Shield and Audit Protection
2026 is a critical year for SALSA. Labs are now required to report private payer data to CMS to prevent massive 15% rate cuts. Data reporting determines your future reimbursement. Our denial management platform automatically aggregates and normalizes the private payer payment data required for SALSA reporting, ensuring your lab contributes accurate market rates to CMS. We don't just recover revenue; we protect your future rates by ensuring your reported data to CMS is accurate and audit‑proof under the 2026 SALSA mandates. This protects the CLFS (Clinical Laboratory Fee Schedule) from arbitrary rate cuts.
For out‑of‑network or cash‑pay patients, transparency is law. We automate the generation of Good Faith Estimates (GFE) and the Advanced Explanation of Benefits (AEOB) required under the 2026 NSA Final Rule. This prevents patient disputes, reduces “surprise bill” litigation risk, and keeps you compliant with federal price transparency rules.
Payers use RAC (Recovery Audit Contractors) to claw back money years after payment. We analyze your historical data to find patterns that trigger these audits. We “audit‑proof” your documentation now so you are safe later.
Specialty-Specific Denial Logic
We focus on MolDX, Z‑Codes, and establishing medical necessity for hereditary cancer and PGx panels. We explicitly manage combinatorial PGx logic, ensuring multi‑gene pharmacogenomic panels are billed as a single unit where required, maintaining unit‑level compliance with payer rules. We know how to fight the "genetic counseling not documented" denial.
We strictly monitor qualitative vs. quantitative frequency limits. We ensure your billing frequency matches the patient's risk profile to avoid "frequency exceeded" denials.
We manage the split between the Technical Component (TC) and the Professional Component (26). We ensure 88305 codes are utilized correctly and supported by the pathology report.
Worried About SALSA Reporting or RAC Audits?
Security and Technology Standards
2026 Margin Protection: Turning Denial Management into a Profit Center
Frequently Asked Questions